EUVIMEDEUVIMED entdecken
Crossref

Exploratory Studies of Effective Inhibitors against the SARS-CoV-2 Main Protease by Halogen Incorporation and Amide Bond Replacement

Kohei Tsuji, Takuya Kobayakawa, Takahiro Ishii, Nobuyo Higashi-Kuwata, Chika Azuma, Kouki Shinohara, Yutaro Miura, Kenichi Yamamoto, Soshi Nishimura, Shin-Ichiro Hattori, Haydar Bulut, Hiroaki Mitsuya und 1 weitere

Chemical and Pharmaceutical Bulletin · 2023

DOI: 10.1248/cpb.c23-00562 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical and Pharmaceutical Bulletin, 2023. Verfasst von Kohei Tsuji und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU). Hauptthemen laut MEDLINE: COVID-19, Pyrrolidines, Benzothiazoles. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 53 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19PyrrolidinesBenzothiazolesAnimalsMiceAmidesAntiviral AgentsHalogensProtease InhibitorsSARS-CoV-2Viral Nonstructural ProteinsCoronavirus 3C ProteasesIndazolesTriazinesTriazoles

Stichwörter der Autor:innen

amide bond surrogatecoronavirus disease of 2019 (COVID-19)fluorinationmain protease inhibitorsevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Substanzen

AmidesAntiviral AgentsHalogensProtease InhibitorsViral Nonstructural ProteinsPyrrolidinesBenzothiazoles3C-like proteinase, SARS-CoV-2Coronavirus 3C Proteasesensitrelvir

Autor:innen und Institutionen

  • Department of Medicinal Chemistry, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU).
  • Department of Refractory Viral Infections, National Center for Global Health and Medicine Research Institute.
  • Experimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health.
  • Department of Clinical Sciences, Kumamoto University Hospital.

Zitieren

APA

Tsuji, K., Kobayakawa, T., Ishii, T., Higashi-Kuwata, N., Azuma, C., Shinohara, K., Miura, Y., Yamamoto, K., Nishimura, S., Hattori, S. I., Bulut, H., Mitsuya, H., & Tamamura, H. (2023). Exploratory Studies of Effective Inhibitors against the SARS-CoV-2 Main Protease by Halogen Incorporation and Amide Bond Replacement. Chemical and Pharmaceutical Bulletin. https://doi.org/10.1248/cpb.c23-00562

Vancouver

Tsuji K, Kobayakawa T, Ishii T, Higashi-Kuwata N, Azuma C, Shinohara K, et al. Exploratory Studies of Effective Inhibitors against the SARS-CoV-2 Main Protease by Halogen Incorporation and Amide Bond Replacement. Chemical and Pharmaceutical Bulletin. 2023. doi:10.1248/cpb.c23-00562

BibTeX
@article{Tsuji2023,
  author = {Tsuji, Kohei and Kobayakawa, Takuya and Ishii, Takahiro and Higashi-Kuwata, Nobuyo and Azuma, Chika and Shinohara, Kouki and Miura, Yutaro and Yamamoto, Kenichi and Nishimura, Soshi and Hattori, Shin-Ichiro and Bulut, Haydar and Mitsuya, Hiroaki and Tamamura, Hirokazu},
  title = {Exploratory Studies of Effective Inhibitors against the SARS-CoV-2 Main Protease by Halogen Incorporation and Amide Bond Replacement},
  journal = {Chemical and Pharmaceutical Bulletin},
  year = {2023},
  doi = {10.1248/cpb.c23-00562}
}
Kostenlos starten →